Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.3B | 2.4B | 2.0B | 2.0B |
Cost of revenue | 795.7M | 771.3M | 664.2M | 637.2M |
Gross profit | 1.5B | 1.6B | 1.4B | 1.4B |
Operating expense | ||||
Research & development | 316.2M | 294.7M | 286M | 280.1M |
Selling general and admin | 563.4M | 612.6M | 510.6M | 525.3M |
Other operating expenses | — | — | — | — |
Operating income | 578.1M | 734.9M | 577.3M | 567.3M |
Non operating interest income | ||||
Income | 90.4M | 74.9M | 93.7M | 87.2M |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 668.5M | 809.8M | 671M | 654.5M |
Tax provision | -35.2M | 121.8M | 100.4M | 123M |
Net income | 703.7M | 688M | 570.6M | 531.5M |
Basic EPS | 2.0 | 1.9 | 1.6 | 1.5 |
Diluted EPS | 1.9 | 1.9 | 1.6 | 1.5 |
Basic average shares | 357.5M | 356.4M | 355.8M | 355M |
Diluted average shares | 364.6M | 363.9M | 362.7M | 361M |
EBITDA | 719M | 859.6M | 693.5M | 679.1M |
Net income from continuing op. | 703.7M | 688M | 570.6M | 531.5M |
Minority interests | -5.3M | -2.3M | -5.5M | -4.6M |
Preferred stock dividends | — | — | — | — |